Table Of Content

Journal of the Neurological Sciences, 114 (1993) 237-239 Elsevier Science Publishers B.V. Author Index (Vol. 114) Abramsky, O., see Brenner, T. (114) 13 Figols, J., see Pascual, J. (114) 165 Abs, R., see De Paepe, L. (114) 152 Foster, D.H., see Honan, W.P. (114) 188 Annunziata, P., see Simone, I.L. (114) 49 Fujiyama, J., see Mimura, Y. (114) 227 Anzinger, G., see Lagréze, H.L. (114) 25 Gendron, D., see Trojan, D.A. (114) 170 Bannister, N., see Dunn, J.F. (114) 76 Getenet, J.-C., Ventre, J., Vighetto, A. and Tadary, B. Barkhof, F., see Scheltens, P. (114) 7 Saccades in internuclear ophthalmoplegia: are abduction disor- Berciano, J., see Pascual, J. (114) 165 ders related to interocular disconjugacy? (114) 160 Bienzle, U., see Stoltenburg-Didinger, G. (114) 20 Goate, A., see Brown, J. (114) 138 Birmanns, B., see Saphier, D. (114) 200 Gonalons, E., see Navarro, X. (114) 56 Blass, J.P., see Jung, E.-H. (114) 123 Gonzalez, A.M., see Pascual, J. (114) 165 Brenner, T. and Abramsky, O. Goto, I., Taniwaki, T., Hosokawa, S., Otsuka, M., Ichiya, Y. and Natural and experimental transfer of anti-Pertussis antibodies Ichimiya, A. confers resistance to experimental autoimmune encephalomyeli- Positron emission tomographic (PET) studies in dementia (114) 1 tis (114) 13 Grijalba, B., see Pascual, J. (114) 165 Brenner, T., see Saphier, D. (114) 200 Groen, R.J.M., Sie, O.G. and Van Weerden, T.W. Brown, J., Gydesen, S., Sorensen, S.A., Brun, A., Smith, $., Houlden, Dominant inherited distal spinal muscular atrophy with atrophic H., Twells, R., Mullan, M., Rossor, M., Collinge, J., Palmer, M., and hypertrophic calves (114) 81 Goate, A. and Hardy, J. Guerrero, J., see Navarro, X. (114) 56 Genetic characterization of a familial non-specific dementia orig- Gydesen, S., see Brown, J. (114) 138 inating in Jutland, Denmark (114) 138 Brun, A., see Brown, J. (114) 138 Haerer, A.F., see Nadeau, S.E. (114) 128 Buti, M., see Navarro, X. (114) 56 Hallett, M. and Dubinsky, R.M. Glucose metabolism in the brain of patients with essential tremor Cashman, N.R., see Trojan, D.A. (114) 170 (114) 45 Chancellor, A.M., see Willison, H.J. (114) 209 Hanihara, T., see Onishi, H. (114) 205 Chopp, M., see Vande Linde, A.M.Q. (114) 36 Hardy, J., see Brown, J. (114) 138 Clemens, A., see De Paepe, L. (114) 152 Hartmann, A., see Lagréze, H.L. (114) 25 Collinge, J., see Brown, J. (114) 138 Hawkins, S., see McEneaney, D. (114) 331 Cruz, M., see Vrethem, M. (114) 193 Heron, J.R., see Honan, W.P. (114) 188 Cuppini, R. Herrero, M.T., see Luquin, M.R. (114) 40 Age-related changes in maturation of regenerated motor innerva- Holmgren, H., see Vrethem, M. (114) 193 tion (114) 99 Honan, W.P., Heron, J.R., Foster, D.H., Edgar, G.K. and Scase, M.O. Abnormalities of visual function in hereditary motor and sensory Deister, A., see Lagréze, H.L. (114) 25 neuropathy (114) 188 De Paepe, L., Abs, R., Verlooy, J., Clemens, A., Smets, R.M.E., Hori, A., see Nakatake, N. (114) 144 Louis, P. and Martin, J.-J. Hosokawa, S., see Goto, I. (114) 1 Benign intracranial hypertension as a cause of transient partial Houlden, H., see Brown, J. (114) 138 pituitary deficiency (114) 152 Dubinsky, R.M., see Hallett, M. (114) 45 Dunn, J.F., Bannister, N., Kemp, G.J. and Publicover, S.J. Ichimiya, A., see Goto, I. (114) 1 Sodium is elevated in mdx muscles: ionic interactions in dys- Ichiya, Y., see Goto, I. (114) 1 trophic cells (114) 76 Ikeda, K., see Iwasaki, Y. (114) 223 Dunnewold, R., see Van Hilten, J.J. (114) 68 Inoue, K., see Onishi, H. (114) 205 Iwasaki, Y., Kinoshita, M., Ikeda, K., Shiojima, T. and Kurihara, T. Neuropsychological function before and after plasma exchange in Edgar, G.K., see Honan, W.P. (114) 188 myasthenia gravis (114) 223 Eling, W.M.C., see Stoltenburg-Didinger, G. (114) 20 Ernerudh, J., see Vrethem, M. (114) 193 Esiri, M.M., Morris, C.S. and Millard, P.R. Jordan, J.E., see Nadeau, S.E. (114) 128 Sensory and sympathetic ganglia in HIV-1 infection: immunocy- Jordan, J.E., see Nadeau, S.E. (114) 156 tochemical demonstration of HIV-1 viral antigens, increased Jung, E.-H., Sheu, K.-F.R. and Blass, J.P. MHC class II antigen expression and mild reactive inflammation An enzymatic and immunochemical analysis of transketolase in (114) 178 fibroblasts from Wernicke-Korsakoff syndrome (114) 123 238 Kameda, N., Kobayashi, T., Park-Matsumoto, Y.C., Tsukagoshi, H. Nagatomo, H., see Onishi, H. (114) 205 and Shimizu, T. Naito, H., see Nakatake, N. (114) 144 Developmental studies of. the expression of myosin heavy chain Nakatake, N., Hori, A., Yasuhara, A., Naito, H. and Yasuhara, M. isoforms in cultured human muscle aneurally and innervated with Oscillatory potentials of visual evoked potentials using source fetal rat spinal cord (114) 85 derivation technique in rabbits (114) 144 Kawamoto, S., see Onishi, H. (114) 205 Nauta, J.J.P., see Scheltens, P. (114) 7 Keli¢, S., Olsson, T. and Kristensson, K. Navarro, X., Verdi, E., Guerrero, J., Buti, M. and Gonalons, E. Interferon-gamma promotes proliferation of rat skeletal muscle Abnormalities of sympathetic sudomotor function in experimen- cells in vitro and alters their AChR distribution (114) 62 tal acrylamide neuropathy (114) 56 Kemp, G.J., see Dunn, J.F. (114) 76 Neifer, S., see Stoltenburg-Didinger, G. (114) 20 Kennedy, P.G.E., see Willison, H.J. (114) 209 Kerkhof, G.A., see Van Hilten, J.J. (114) 68 Obeso, J.A., see Luquin, M.R. (114) 40 Kimura, S., see Onishi, H. (114) 205 Okuda, K., see Onishi, H. (114) 205 Kinoshita, M., see Iwasaki, Y. (114) 223 Olsson, T., see Kelié, S. (114) 62 Kobayashi, T., see Kameda, N. (114) 85 Onishi, H., Inoue, K., Osaka, H., Kimura, S., Nagatomo, H., Hani- Kosaka, K., see Onishi, H. (114) 205 hara, T., Kawamoto, S., Okuda, K., Yamada, Y. and Kosaka, K. Kremsner, P.G., see Stoltenburg-Didinger, G. (114) 20 Mitochondrial myopathy, encephalopathy, lactic acidosis and Kristensson, K., see Keli¢, S. (114) 62 stroke-like episodes (MELAS) and diabetes mellitus: molecular Kurihara, T., see Iwasaki, Y. (114) 223 genetic analysis and family study (114) 205 Kuriyama, M., see Mimura, Y. (114) 227 Osaka, H., see Onishi, H. (114) 205 Osame, M., see Mimura, Y. (114) 227 Lagréze, H.L., Hartmann, A., Anzinger, G., Schaub, A. and Deister, Otsuka, M., see Goto, I. (114) 1 A. Functional cortical interaction patterns in visual perception and Palmer, M., see Brown, J. (114) 138 visuospatial problem solving (114) 25 Park-Matsumoto, Y.C., see Kameda, N. (114) 85 Laguna, J., see Luquin, M.R. (114) 40 Pascual, J., Berciano, J., Gonzalez, A.M., Grijalba, B., Figols, J. and Leante, R., see Simone, I.L. (114) 49 Pazos, A. Lee, S.A., see Vande Linde, A.M.Q. (114) 36 Autoradiographic demonstration of loss of a -adrenoceptors in Lees, G.J. progressive supranuclear palsy: preliminary report (114) 165 The possible contribution of microglia and macrophages to de- Paterson, G., see Willison, H.J. (114) 209 layed neuronal death after ischemia (114) 119 Pazos, A., see Pascual, J. (114) 165 Leys, D., see Scheltens, P. (114) 7 Pilgrim, A.J., see Tansey, M.J.B. (114) 109 Liguori, M., see Simone, I.L. (114) 49 Pruvo, J.P., see Scheltens, P. (114) 7 Livrea, P., see Simone, I.L. (114) 49 Publicover, S.J., see Dunn, J.F. (114) 76 Lloyd, K., see Tansey, M.J.B. (114) 109 Lockwood, R.J., see Wilson, S.A. (114) 216 Rossor, M., see Brown, J. (114) 138 Louis, P., see De Paepe, L. (114) 152 Luquin, M.R., Laguna, J., Herrero, M.T. and Obeso, J.A. Behavioral tolerance to repeated apomorphine administration in Saphier, D., Birmanns, B. and Brenner, T. parkinsonian monkeys (114) 40 Electroencephalographic changes in experimental autoimmune myasthenia gravis (114) 200 Scase, M.O., see Honan, W.P. (114) 188 Maimone, D., see Simone, I.L. (114) 49 Schaub, A., see Lagréze, H.L. (114) 25 Malm, C., see Vrethem, M. (114) 193 Scheltens, P., Barkhof, F., Leys, D., Pruvo, J.P., Nauta, J.J.P., Verm- Martin, J.-J., see De Paepe, L. (114) 152 ersch, P., Steinling, M. and Valk, J. Mastaglia, F.L., see Wilson, S.A. (114) 216 A semiquantative rating scale for the assessment of signal hyper- McEneaney, D., Hawkins, S., Trimble, E. and Smye, M. intensities on magnetic resonance imaging (114) 7 Porphyric neuropathy — a rare and often neglected differential Schultz, L.R., see Vande Linde, A.M.Q. (114) 36 diagnosis of Guillain-Barré syndrome (114) 331 Sheu, K.-F.R., see Jung, E.-H. (114) 123 Miike, T., see Zhao, J.-e. (114) 104 Shimizu, T., see Kameda, N. (114) 85 Millard, P.R., see Esiri, M.M. (114) 178 Shiojima, T., see Iwasaki, Y. (114) 223 Mimura, Y., Kuriyama, M., Tokimura, Y., Fujiyama, J., Osame, M., Sie, O.G., see Groen, R.J.M. (114) 81 Takesako, K. and Tanaka, N. Simone, I.L., Annunziata, P., Maimone, D., Liguori, M., Leante, R. Treatment of cerebrotendinous xanthomatosis with low-density and Livrea, P. lipoprotein (LDL)-apheresis (114) 227 Serum and CSF anti-GM1 antibodies in patients with Guillain- Mishra, S.K., see Nadeau, S.E. (114) 128 Barré syndrome and chronic inflammatory demyelinating Mishra, S.K., see Nadeau, S.E. (114) 156 polyneuropathy (114) 49 Miyatake, M., see Zhao, J.-e. (114) 104 Singh, S., see Willison, H.J. (114) 209 Morris, C.S., see Esiri, M.M. (114) 178 Smets, R.M.E., see De Paepe, L. (114) 152 Mullan, M., see Brown, J. (114) 138 Smith, S., see Brown, J. (114) 138 Smye, M., see McEneaney, D. (114) 331 Nadeau, S.E., Jordan, J.E. and Mishra, S.K. Sorensen, S.A., see Brown, J. (114) 138 Factors associated with occurrence of large vessel and lacunar Steinling, M., see Scheltens, P. (114) 7 cerebral infarctions (114) 156 Stoltenburg-Didinger, G., Neifer, S., Bienzle, U., Eling, W.M.C. and Nadeau, S.E., Jordan, J.E., Mishra, S.K. and Haerer, A.F. Kremsner, P.G. Stroke rates in patients with lacunar and large vessel cerebral Selective damage of hippocampal neurons in murine cerebral infarctions (114) 128 malaria prevented by pentoxifylline (114) 20 239 Tadary, B., see Getenet, J.-C. (114) 160 Vighetto, A., see Getenet, J.-C. (114) 160 Takesako, K., see Mimura, Y. (114) 227 Vrethem, M., Cruz, M., Wen-Xin, H., Malm, C., Holmgren, H. and Tanaka, N., see Mimura, Y. (114) 227 Ernerudh, J. Taniwaki, T., see Goto, I. (114) 1 Clinical, neurophysiological and immunological evidence of Tansey, M.J.B., Pilgrim, A.J. and Lloyd, K. polyneuropathy in patients with monoclonal gammopathies (114) Sumatriptan in the acute treatment of migraine (114) 109 193 Thickbroom, G.W., see Wilson, S.A. (114) 216 Tokimura, Y., see Mimura, Y. (114) 227 Warlow, C.P., see Willison, H.J. (114) 209 Trimble, E., see McEneaney, D. (114) 331 Welch, K.M.A., see Vande Linde, A.M.Q. (114) 36 Trojan, D.A., Gendron, D. and Cashman, N.R. Wen-Xin, H., see Vrethem, M. (114) 193 Anticholinesterase-responsive neuromuscular junction transmis- Whitelaw, J., see Willison, H.J. (114) 209 sion defects in post-poliomyelitis fatigue (114) 170 Willison, H.J., Chancellor, A.M., Paterson, G., Veitch, J., Singh, S., Tsukagoshi, H., see Kameda, N. (114) 85 Whitelaw, J., Kennedy, P.G.E. and Warlow, C.P. Twells, R., see Brown, J. (114) 138 Antiglycolipid antibodies, immunoglobulins and paraproteins in motor neuron disease: a population based case-control study Valk, J., see Scheltens, P. (114) 7 (114) 209 Vande Linde, A.M.Q., Chopp, M., Lee, S.A., Schultz, L.R. and Wilson, S.A., Lockwood, R.J., Thickbroom, G.W. and Mastaglia, Welch, K.M.A. FE. Post-ischemic brain tissue alkalosis suppressed by U74006F (114) The muscle silent period following transcranial magnetic cortical 36 stimulation (114) 216 Van Dijk, J.G., see Van Hilten, J.J. (114) 68 Wintzen, A.R., see Van Hilten, J.J. (114) 68 Van Hilten, J.J., Kerkhof, G.A., Van Dijk, J.G., Dunnewold, R. and Wintzen, A.R. Disruption of sleep-wake rhythmicity and daytime sleepiness in Yamada, Y., see Onishi, H. (114) 205 myotonic dystrophy (114) 68 Yasuhara, A., see Nakatake, N. (114) 144 Van Weerden, T.W., see Groen, R.J.M. (114) 81 Yasuhara, M., see Nakatake, N. (114) 144 Veitch, J., see Willison, H.J. (114) 209 Yoshioka, K., see Zhao, J.-e. (114) 104 Ventre, J., see Getenet, J.-C. (114) 160 Verda, E., see Navarro, X. (114) 56 Zhao, J.-e., Yoshioka, K., Miike, T. and Miyatake, M. Verlooy, J., see De Paepe, L. (114) 152 Developmental studies of dystrophin-positive fibers in mdx, and Vermersch, P., see Scheltens, P. (114) 7 DRP localization (114) 104 Journal of the Neurological Sciences, 114 (1993) 241-242 Elsevier Science Publishers B.V. Subject Index (Vol. 114) Abduction nystagmus, (114) 160 Factor analysis, (114) 25 Acetylcholine receptor, (114) 62, (114) 200 Familial dementia, (114) 138 Acrylamide, (114) 56 Fasciculations, (114) 81 Acute porphyria, (114) 331 Fatigue, (114) 170 a>-Adrenoceptors, (114) 165 Fibroblast, (114) 123 Age, (114) 99 Frontal lobe dementia, (114) 138 Alzheimer’s disease, (114) 7 Antibody, (114) 49 Ganglioside, (114) 49 Anticholinesterase, (114) 170 Glucose, (114) 1 Anti-myelin basic protein antibodies, (114) 13 Glucose metabolism, (114) 45 Anti-peripheral nervemyelin antibodies, (114) 193 GM1, (114) 49 Anti-pertussis antibodies, (114) 13 GM1 ganglioside, (114) 209 Autoantibodies, (114) 209 Growth factors, (114) 119 Autoimmunity, (114) 209 Guillain-Barré syndrome, (114) 49 Brain tissue alkalosis, (114) 36 Hereditary motor and sensory neuropathy, (114) 188 Bromo[*H]oxidine, (114) 165 Hereditary motor neuron disease, (114) 81 Higher cortical functions, (114) 25 Hippocampus, (114) 20 Central cholinergic function, (114) 223 Histochemistry, (114) 85 Central nervous system, (114) 200 HIV-1 infect/iA oIDnS, (114) 178 Cerebellum, (114) 45 Human muscle culture, (114) 85 Cerebral blood flow, (114) 25 Hypertrophic calves, (114) 81 Cerebral malaria, (114) 20 Hypopituitarism, (114) 152 Cerebrospinal fluid, (114) 200 Cerebrotendinous xanthomatosis (CTX), (114) 227 Immunoblot analysis, (114) 104 Cholestanol, (114) 227 Immunocytochemistry, (114) 178 Cholesterol, (114) 227 Immunoglobulin, (114) 193 Chronic inflammatory demyelinating polyneuropathy, (114) 49 Immunoglobulins, (114) 209 Clinical trials, (114) 109 Immunohistochemistry, (114) 85, (114) 104 Cognition, (114) 25 Inferior olivary nucleus, (114) 45 Colour vision, (114) 188 Innervation, (114) 85 Cortical infarction, (114) 128, (114) 156 Interferon-y, (114) 62 Cortical visual system, (114) 25 Internuclear ophthalmoplegia, (114) 160 Ions, (114) 76 Delayed neuronal death, (114) 119 Ischemia, (114) 119 Dementia, (114) 1, (114) 7 Diabetes mellitus, (114) 205 Lactation, (114) 13 Distal spinal muscular atrophy, (114) 81 Lacunar infarction, (114) 128, (114) 156 Disturbed rhythmicity, (114) 68 Linkage analysis, (114) 138 Duchenne muscular dystrophy, (114) 76 Locus ceruleus, (114) 165 Dystrophin, (114) 104 Low density lipoprotein-apheresis (LDL-apheresis), (114) 227 Dystrophin-related protein, (114) 104 Macrophages, (114) 119 Electroencephalogram, (114) 200 Magnetic stimulation, (114) 216 Electromyography, (114) 170 Maternal inheritance, (114) 205 Electro-oculography, (114) 160 max, (114) 76 Empty sella syndrome, (114) 152 mdx mouse, (114) 104 Enzyme-linked immunosorbent assay, (114) 193 MELAS, (114) 205 Essential tremor, (114) 45 Memory function, (114) 223 Excessive daytime sleepiness, (114) 68 Microglia, (114) 119 Excitotoxins, (114) 119 Microsatellite probes, (114) 138 Expetimental autoimmune encephalomyelitis, (114) 13 Migraine, (114) 109 Experimental autoimmune myasthenia gravis, (114) 200 Miniature endplate potentials, (114) 99 Extensor digitorum longus muscle, (114) 99 Mitochondrial DNA, (114) 205 242 Mitochondrial encephalomyopathy, (114) 205 Polyneuropathy, (114) 193 Monoclonal antibody, (114) 85 Positron emission tomography, (114) 1, (114) 45 Monoclonal gammopathy, (114) 193 Postpoliomyelitis syndrome, (114) 170 Motor cortex, (114) 216 Progressive supranuclear palsy, (114) 165 Motor evoked potential, (114) 216 Pseudotumor cerebri, (114) 152 Motor function, (114) 56 Motor neuron disease, (114) 209 Quantitative autoradiography, (114) 165 MRI, (114) 7 Multivariate data analysis, (114) 25 Rabbit, (114) 144 Muscle, (114) 76 Rat, (114) 99 Muscle fiber type differentiation, (114) 85 Rat forebrain ischemia, (114) 36 Muscle reinnervation, (114) 99 Repetitive dopaminergic stimulation, (114) 40 Myasthenia gravis, (114) 200, (114) 223 Respiratory failure, (114) 331 Myelin associated glycoprotein, (114) 193 Risk factors, (114) 156 Myoblast, (114) 62 Myogenesis, (114) 62 Saccades, (114) 160 Myosin heavy chain isoform, (114) 85 Sensory /sympathetic ganglia, (114) 178 Myotonic dystrophy, (114) 68 Signal hyperintensities, (114) 7 Myotube, (114) 62 Silent period, (114) 216 Single fiber electromyography, (114) 170 Nerve regeneration, (114) 99 Skeletal muscle, (114) 62 Neurological diseases, (114) 119 Sodium, (114) 76 Neuromuscular junction, (114) 170 Source derivation, (114) 144 Neuronal networks, (114) 25 Stroke, (114) 156 Neuron damage, (114) 20 Stroke recurrence, (114) 128, (114) 156 Neuropathology, (114) 178 Subcutaneous, (114) 109 Neuropathy, (114) 56, (114) 331 Sumatriptan, (114) 109 Neurophysiology, (114) 193 Sweat gland, (114) 56 Neurotoxicity, (114) 56 Nitric oxide, (114) 119 31P-NMR, (114) 36 Sympathetic nerve, (114) 56 Non-specific dementia, (114) 138 Temporal contrast sensitivity, (114) 188 Thalamus, (114) 45 Oral, (114) 109 Tolerance, (114) 40 Overshoot, (114) 160 Topography, (114) 144 Transketolase, (114) 123 Paraproteins, (114) 209 Parkinson’s disease, (114) 40 U74006F, (114) 36 Partial correlation coefficients, (114) 25 Visual evoked potential, (114) 144 Pentoxifylline, (114) 20 Visual evoked potentials, (114) 188 Pertussis vaccine, (114) 13 Pick’s disease, Prion disease, (114) 138 Wernicke-Korsakoff syndrome, (114) 123 Polyneuronal innervation, (114) 99 White matter, (114) 7